Eli Lilly’s Experimental Pill Could Help You Ditch GLP-1 Obesity Shots, Trial Finds

Good news for people on GLP-1 therapy who hate needles: Trial data out this week shows that an experimental pill developed by Eli Lilly could offer an intriguing off-ramp.

On Thursday morning, Eli Lilly presented the results of its latest phase III trial of the drug, named orforglipron. People taking the once-daily pill were largely able to keep off the weight they originally lost taking a different GLP-1 injectable. The company is already seeking the FDA’s approval of orforglipron,…